These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20015619)

  • 1. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.
    Sink KS; Segovia KN; Sink J; Randall PA; Collins LE; Correa M; Markus EJ; Vemuri VK; Makriyannis A; Salamone JD
    Eur Neuropsychopharmacol; 2010 Feb; 20(2):112-22. PubMed ID: 20015619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.
    Sink KS; Segovia KN; Nunes EJ; Collins LE; Vemuri VK; Thakur G; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2009 Oct; 206(2):223-32. PubMed ID: 19588124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
    Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
    Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats.
    Sink KS; Segovia KN; Collins LE; Markus EJ; Vemuri VK; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2010 Jun; 95(4):479-84. PubMed ID: 20347865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.
    Sink KS; McLaughlin PJ; Wood JA; Brown C; Fan P; Vemuri VK; Peng Y; Olszewska T; Thakur GA; Makriyannis A; Parker LA; Salamone JD
    Neuropsychopharmacology; 2008 Mar; 33(4):946-55. PubMed ID: 17581535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113.
    Sink KS; Vemuri VK; Wood J; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2009 Jan; 91(3):303-6. PubMed ID: 18703081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior.
    Sink KS; Vemuri VK; Olszewska T; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 2008 Mar; 196(4):565-74. PubMed ID: 18004546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neutral CB1 receptor antagonist reduces weight gain in rat.
    Chambers AP; Vemuri VK; Peng Y; Wood JT; Olszewska T; Pittman QJ; Makriyannis A; Sharkey KA
    Am J Physiol Regul Integr Comp Physiol; 2007 Dec; 293(6):R2185-93. PubMed ID: 17959701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice.
    Rodgers RJ; Evans PM; Murphy A
    Behav Pharmacol; 2005 Sep; 16(5-6):405-13. PubMed ID: 16148445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions.
    Salamone JD; McLaughlin PJ; Sink K; Makriyannis A; Parker LA
    Physiol Behav; 2007 Jul; 91(4):383-8. PubMed ID: 17521686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cannabinoid receptor CB₁ inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala.
    Dono LM; Currie PJ
    Neuropharmacology; 2012 Jan; 62(1):192-9. PubMed ID: 21736884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FG 7142 specifically reduces meal size and the rate and regularity of sustained feeding in female rats: evidence that benzodiazepine inverse agonists reduce food palatability.
    Cottone P; Sabino V; Steardo L; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1069-81. PubMed ID: 17077811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term CB₁ receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids.
    Tambaro S; Tomasi ML; Bortolato M
    Neuropharmacology; 2013 Jul; 70():268-77. PubMed ID: 23462228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid system of the lateral septum in the modulation of anxiety-like behaviors in rats.
    Hajizadeh Moghaddam A; Bigdellu R; Fatemi Tabatabaei SR; Roohbakhsh A
    Arch Iran Med; 2013 Dec; 16(12):711-6. PubMed ID: 24329144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice.
    Reddy DS; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):665-81. PubMed ID: 9542718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid CB
    He XH; Jordan CJ; Vemuri K; Bi GH; Zhan J; Gardner EL; Makriyannis A; Wang YL; Xi ZX
    Acta Pharmacol Sin; 2019 Mar; 40(3):365-373. PubMed ID: 29967454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT
    McLaughlin PJ; Jagielo-Miller JE; Plyler ES; Schutte KK; Vemuri VK; Makriyannis A
    Psychopharmacology (Berl); 2017 Mar; 234(6):1029-1043. PubMed ID: 28144708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats.
    Limebeer CL; Vemuri VK; Bedard H; Lang ST; Ossenkopp KP; Makriyannis A; Parker LA
    Br J Pharmacol; 2010 Sep; 161(2):336-49. PubMed ID: 20735419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.